Supplementing with the lactic acid bacterium Lactococcus lactis strain Plasma (LC-Plasma) can “alleviate fatigue accumulation caused by a continuous high training load,” a new randomised, double-blind, placebo-controlled study finds.
Japan: Using icosapent ethyl, a purified eicosapentaenoic acid (EPA), alongside statin therapy, may reduce the risk of adverse cardiovascular events in chronic coronary artery disease (CAD) patients,.
Although the open-label trial has many limitations, it could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose eicosapentaenoic acid.